Dublin, Ireland, 15th February 2007 - AGI Therapeutics plc ("AGI" or the "Company") (AIM, IEX: AGI), a speciality pharmaceutical company focused on gastrointestinal drug products, today announces continued progress on key development programmes and outlines its plans for these programmes in 2007.
